Clinical Research

Found 101,398 articles

• Blood Journal Study: Sickle Cell Anemia Treatment Does Not Increase Malaria Risk in Africa

  10/20/2017

  The drug hydroxyurea does not appear to increase the risk of malaria infection in patients with sickle cell anemia who live in malaria-endemic regions, according to a study published online today in Blood, the Journal of the American Society of Hematology (ASH).

• Albert Einstein College of Medicine Release: Study Shows How Nerves Drive Prostate Cancer

  10/20/2017

  n a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.

• ACEA Biosciences Release: Characterizing Bacteriophage-Derived Enzymes That Degrade Staphylococcus Biofilms

  10/20/2017

  Biofilms are surface-attached communities of bacterial or fungal cells that are enmeshed in an extensive extracellular matrix which makes them more resistant to both antibiotics and the immune system.

• UNH Researchers Create New Concept That Could Lead to Improved Drug Delivery

  10/20/2017

  Inspired by a color changing mechanism found in cephalopods, like squid, cuttlefish and octopus, researchers at the University of New Hampshire have conceived a design for a unique sequential cell-opening mechanism that has many potential applications from drug delivery to color altering camouflage materials.

• Florida International University Release: Can Adults Develop ADHD? Research Says Probably Not

  10/20/2017

  Adults likely do not develop ADHD, according to new research by FIU clinical psychologist Margaret Sibley.

• 

  Meet the Scientist Who's Trying to Grow Human Organs in Pigs

  10/20/2017

  Biologist Dr. Pablo Juan Ross is no stranger to cutting-edge tools such as CRISPR and stem cells.

• Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Inborn Errors of Metabolism at The Liver Meeting 2017 (AASLD)

  10/20/2017

  This data will be presented by Vaidehi Joshi, Scientist I, Therapeutics, at Organovo.

• CombiMatrix to Present New Data From a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting

  10/20/2017

  Results from nearly 32,000 samples analyzed in this study indicate that genomic alterations decrease in frequency and severity from conception through development into childhood.

• Children's Hospital of Philadelphia and Edico Genome Achieve Fastest-Ever Analysis of 1,000 Genomes

  10/20/2017

  The Children's Hospital of Philadelphia (CHOP) and Edico Genome today set a new scientific world standard in rapidly processing whole human genomes into data files useable for researchers aiming to bring precision medicine into mainstream clinical practice.

• Children's Hospital Los Angeles to Conduct Brain Imaging Research in Premature Babies to Identify Biomarkers Linked to Cognitive and Behavioral Disorders

  10/20/2017

  Natasha Leporé, PhD, a principal investigator in the Department of Radiology and Imaging at Children's Hospital Los Angeles, has been awarded $1.7 million from the National Institute of Biomedical Imaging and Bioengineering of the NIH.

• QIAGEN Announces High Accuracy of Bioinformatics Solutions in Women's Health Genetic Screening

  10/20/2017

  QIAGEN today announced the results of a study evaluating the accuracy of the QIAGEN Clinical Insight (QCI) solution by Counsyl, a genetic screening and genetic counseling company.

• Avinger Announces First Patient Enrolled in its IDE Study of the Pantheris Image-Guided Atherectomy System for Treatment of In-Stent Restenosis

  10/20/2017

  Up to 140 patients will be enrolled in the INSIGHT trial at up to 20 U.S. and international centers.

• Zogenix: High Seizure Frequency in Children With Dravet Syndrome Negatively Impacts Quality of Life, New International Caregiver Survey Finds

  10/19/2017

  The results suggest a need for more effective antiepileptic treatments.

• Q BioMed Announces Identification and Production of New Proprietary Drug Candidate for Pediatric Nonverbal Disorder

  10/19/2017

  Q BioMed today that it has successfully developed a new and proprietary analog of QBM-001 in partnership with Sphaera Pharma for its intended use in pediatric developmental nonverbal disorder.

• CytoSorbents Release: CytoSorb Usage During Valve Replacement Surgery for Infective Endocarditis Helps Stabilize Patients and May Improve Survival

  10/19/2017

  CytoSorbents highlights the largest endocarditis valve replacement study using CytoSorb published to date entitled, "Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series".

• Myriad's GeneSight Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine Use

  10/19/2017

  The positive results were presented at the 25th World Congress of Psychiatric Genetics.

• Pixium Vision Receives Approval For First-In-Human Clinical Trial Of PRIMA, Its Miniaturized Sub-Retinal Implant

  10/19/2017

  Pixium Vision announces that its next-generation miniaturized wireless sub-retinal implant, PRIMA, received authorization from the French regulatory agency, to start a feasibility clinical study in patients with advanced dry age-related macular degeneration (dry-AMD).

• Novartis Drug Revolade Shows Long-Term Disease Control for Chronic/Persistent Immune Thrombocytopenia (ITP)

  10/18/2017

  The long term study results were published online in Blood.

• Novartis Drug Promacta Shows Long-Term Disease Control For Chronic/Persistent Immune Thrombocytopenia

  10/18/2017

  Novartis today announced long-term study results supporting the positive safety and efficacy of Promacta (eltrombopag) in adults with chronic/persistent immune (idiopathic) thrombocytopenia (ITP).

• PharmaCyte Biotech Research Identifies Enzyme Activity for Cannabinoid-Based Therapy to Fight Cancer

  10/18/2017

  PharmaCyte Biotech announced that its research partner, the University of Northern Colorado, has identified an organism whose genome contains the genetic code for production of an enzyme capable of activating a cannabinoid prodrug into its active cancer-killing form.